| Literature DB >> 23850600 |
Patrick Murphy1, Tim Shallice, Gail Robinson, Sarah E MacPherson, Martha Turner, Katherine Woollett, Marco Bozzali, Lisa Cipolotti.
Abstract
The proverb interpretation task (PIT) is often used in clinical settings to evaluate frontal "executive" dysfunction. However, only a relatively small number of studies have investigated the relationship between frontal lobe lesions and performance on the PIT. We compared 52 patients with unselected focal frontal lobe lesions with 52 closely matched healthy controls on a proverb interpretation task. Participants also completed a battery of neuropsychological tests, including a fluid intelligence task (Raven's Advanced Progressive Matrices). Lesions were firstly analysed according to a standard left/right sub-division. Secondly, a finer-grained analysis compared the performance of patients with medial, left lateral and right lateral lesions with healthy controls. Thirdly, a contrast of specific frontal subgroups compared the performance of patients with medial lesions with patients with lateral frontal lesions. The results showed that patients with left frontal lesions were significantly impaired on the PIT, while in patients with right frontal lesions the impairments approached significance. Medial frontal patients were the only frontal subgroup impaired on the PIT, relative to healthy controls and lateral frontal patients. Interestingly, an error analysis indicated that a significantly higher number of concrete responses were found in the left lateral subgroup compared to healthy controls. We found no correlation between scores on the PIT and on the fluid intelligence task. Overall our results suggest that specific regions of the frontal lobes contribute to the performance on the PIT.Entities:
Keywords: Executive function; Fluid intelligence; PFC; Proverbs
Mesh:
Year: 2013 PMID: 23850600 PMCID: PMC4020551 DOI: 10.1016/j.neuropsychologia.2013.06.029
Source DB: PubMed Journal: Neuropsychologia ISSN: 0028-3932 Impact factor: 3.139
Fig. 1Frontal lobe areas used to partition patients into subgroups of interest.
Fig. 3Damage to frontal lobe regions for each frontal patient subgroup. Shading describes percentage of patients from each group with damage to specified area.
Scoring examples for “Rome wasn′t built in a day” proverb.
| “It takes patience and time to complete a great, worthwhile project” ( | 2 |
| “Things take time, but you will get there in the end” ( | 1 |
| “Quit while you are ahead” ( | 0 |
Demographic characteristics—left and right frontal groups and HC’s.
| Age (years) | 46.48 (11.26) | 45.61 (15.76) | 47.35 (14.59) | 0.128 ( |
| Gender (male/female) | 17/12 | 11/12 | 25/27 | 0.944 |
| No. months between surg/VA/neuropsy | 18.16 (26.05) | 22.77 (34.22) | N/A | 0.286 ( |
| No. of brain regions damaged | 3.11 (2.35) | 2.70 (1.66) | N/A | 0.500 ( |
| GNT (no. correct/30) | 20.76 (3.99) | 22.35 (3.97) | 22.77 (3.96) | 2.438 ( |
| NART IQ | 106.10 (15.12) | 111.48 (8.95) | 110.85 (9.83) | 1.990 ( |
SD, standard deviation; HC, healthy controls; no., number; surg, surgery; VA, vascular accident; neuropsy, neuropsychological assessment; N/A, non applicable; GNT, Graded Naming Test; NART, National Adult Reading Test. All significant comparisons in bold.
Chi-squared analysis.
Number of cases missing (left frontal=3).
Proverb interpretation task accuracy—comparison of medial and lateral frontal subgroups.
| Score on proverbs task (% score) | 48.53 (16.76) | 57.76 (23.25) |
SD, standard deviation. All significant comparisons in bold.
p<0.05 (significant group difference between patient group and HC’s).
Eighteen healthy controls and 22 patients were administered four items on the proverbs task, all others were administered eight items. Score represents the patient’s score on the proverbs task expressed as a percentage. See text for guide to method of scoring.
Performance on baseline cognitive tests—left and right frontal groups and HC's.
| RAPM (number correct/12) | 8.00 (2.69) | 8.83 (2.08) | 9.28 (1.66) | 2.116 ( |
| Trails B—time in msec | 90.46 (68.26) ( | 66.45 (21.48) | ||
| Stroop word—no. words | 224.07 (50.30) ( | 244.07 (48.96) | ||
| Stroop colour—no. colours | 95.60 (36.43) ( | 106.74 (23.72) |
SD, standard deviation; HC, healthy controls; no., number. All significant comparisons in bold.
Probability value from post hoc test (patient subgroup versus HC’s).
p<0.05 (significant group difference between patient group and HC’s).
Number of cases missing (HC=2).
Number of cases missing (left frontal=2/HC=5).
Number of cases missing (left frontal=2/right frontal=1/HC=1).
Number of cases missing (left frontal=6/right frontal=2/HC=1).
Performance on baseline cognitive tests—three prefrontal subgroups and HC's.
| RAPM (number correct/12) | 9.00 (2.76) | 7.63 (2.60) | 8.46 (2.30) | 9.36 (1.63) | 1.898 ( |
| Trails B—time in msec | 66.62 (21.44) | ||||
| Stroop word—no. words | 221.52 (53.58) ( | 214.74 (47.56) ( | 248.59 (57.10) | ||
| Stroop colour—no. colours | 101.61 (30.49) | 80.50 (44.63) | 85.22 (41.63) | 105.95 (23.46) | 2.371 ( |
SD, standard deviation; HC, healthy controls; GNT, Graded Naming Test; no., number; msec, milliseconds; RAPM, Raven’s Advanced Progressive Matrices. All significant comparisons in bold.
Probability value from post hoc test (patient subgroup versus HC’s).
p<0.05 (significant group difference between patient group and HC’s).
Number of cases missing (healthy controls=2).
Number of cases missing (left lateral=2/healthy controls=5).
Number of cases missing (medial=1/left lateral=1/right lateral=1/healthy controls=1).
Number of cases missing (medial=2/left lateral=4/right lateral=1/healthy controls=1).
Demographic characteristics—three prefrontal subgroups and HC's.
| Age (years) | 42.29 (10.04) | 47.44 (12.78) | 46.46 (14.74) | 48.38 (14.41) | 0.560 ( |
| Gender (male/female) | 7/10 | 10/6 | 6/7 | 20/26 | 2.006 |
| No. months between surg/VA/neuropsy | 32.71 (39.84) | 18.27 (27.71) | 11.27 (18.94) | N/A | 1.849 ( |
| No. of brain regions damaged | 2.36 (1.66) | 4.06 (2.74) | 3.23 (2.28) | N/A | 2.366 ( |
| NART IQ | 109.18 (11.21) | 104.31 (17.81) | 112.00 (8.803) | 110.64 (9.22) | 1.459 ( |
| GNT (no. correct/30) | 22.59 (4.39) | 19.94 (3.70) | 22.15 (3.46) | 22.50 (3.84) | 2.074 ( |
SD, standard deviation; HC, healthy controls; no., number; surg, surgery; VA, vascular accident; neuropsy, neuropsychological assessment; N/A, non applicable. All significant comparisons in bold.
Chi-squared analysis.
Number of cases missing (medial=1/left lateral =1).
Proverb interpretation task accuracy—comparison of left and right frontal groups and frontal subgroups with HC’s.
| Score on proverbs task (% score) | 57.34 (19.46) | 65.50 (15.60) | |||
| Score on proverbs task (% score) | 56.25 (23.27) ( | 59.62 (24.02) ( | 66.71 (15.60) | ||
SD, standard deviation; HC, healthy controls. All significant comparisons in bold.
Probability value from post hoc test (patient subgroup versus HC’s).
p<0.05 (significant group difference between patient group and HC’s).
Orbital patients and their matched HC’s included.
Fifteen healthy controls and 15 patients were administered four items on the proverbs task, all others were administered eight items. Score represents the patient’s score on the proverbs task expressed as a percentage. See text for guide to method of scoring.
Approaching significance (p=0.059).
Pearson’s r coefficients for correlations of performance on the PIT with the performance on baseline cognitive measures.
| RAPM | 0.170 ( | 0.244 ( | −0.016 ( | 0.316 ( | 0.092 ( | 0.321 ( |
| Trails B—time in msec | −0.271 ( | − | 0.022 ( | −0.475 ( | −0.027 ( | −0.318 ( |
| Stroop word—no. words | 0.106 ( | 0.255 ( | −0.247 ( | 0.269 ( | −0.295 ( | 0.146 ( |
| Stroop colour—no. colours | 0.383 ( | 0.182 ( | 0.415 ( | 0.338 ( | ||
| Graded Naming Test | 0.365 ( | 0.285 ( | 0.441 ( | 0.275 ( |
p<0.05 (significant correlation).
Category of errorsa made by left frontal and right frontal patients and HC's.
| Concrete errors as % of total errors | 13.17 (22.24) ( | 8.31 (19.65) | ||
| Partial errors as % of total errors | 59.60 (36.21) ( | 79.25 (25.64) | ||
| Non-concrete incorrect errors as % of total errors | 17.16 (19.19) | 20.56 (26.82) | 12.44 (18.90) | 1.376 ( |
All significant comparisons in bold.
Probability value from post hoc test (patient subgroup versus HC’s).
p<0.05 (Bonferroni corrected for comparisons between individual patient groups and HC’s).
See Materials and methods section for complete explanation of response categories.
Category of errorsa made by left lateral, right lateral and medial frontal patients and healthy controls.
| Concrete errors as % of total errors | 24.46 (8.71) ( | 12.25 (20.32) ( | 7.59 (20.11) | ||
| Partial errors as % of total errors | 61.60 (36.00) ( | 80.22 (24.81) | |||
| Non-concrete incorrect errors as % of total errors | 35.74 (29.27) ( | 11.09 (14.63) ( | 15.04 (20.39) ( | 12.19 (19.03) | 6.408 ( |
All significant comparisons in bold.
Probability value from post hoc test (patient subgroup versus HC’s).
p<0.05 (Bonferroni corrected for comparisons between individual patient groups and HC’s).
See Materials and methods section for complete explanation of response categories.
Fig. 4Percentage of total errors made by patient subgroups that were concrete errors.
Category of errorsa made by medial and lateral frontal subgroups.
| Concrete errors as % of total errors | 21.38 (24.64) | 30.22 (36.99) | −0.215 (p=0.830) |
| Partial errors as % of total errors | 42.89 (29.27) | 46.91 (36.72) | −0.051 (p=0.980) |
| Non-concrete incorrect errors as % of total errors | 35.74 (29.27) | 12.87 (17.08) | −2.065 (p=0.049) |
See Materials and methods section for complete explanation of response categories.
Patient aetiology (N=48).
| Sub-arachnoid haemorrhage | 3 | 2 |
| Stroke | 1 | 2 |
| Haematoma | 0 | 1 |
| ACoAneurysm | 1 | 1 |
| Astrocytoma unspecified grade | 1 | 1 |
| Glioma unspecified grade | 1 | 0 |
| Glioma—low grade | 0 | 4 |
| Glioma—grade II | 1 | 0 |
| Meningioma unspecified grade | 2 | 5 |
| Meningioma—grade I | 1 | 0 |
| Meningioma—grade II | 1 | 0 |
| Oligodendroglioma unspecified grade | 1 | 1 |
| Oligodendroglioma—grade II | 0 | 2 |
| Oligodendroglioma—grade III | 1 | 0 |
| Glioblastoma unspecified grade | 1 | 2 |
| Glioblastoma—grade IV | 2 | 0 |
| Oligoastrocytoma | 5 | 0 |
| Metastasis | 2 | 0 |
| Tumour unspecified | 3 | 0 |